A clinical study of CP-COV03 for COVID-19
Latest Information Update: 15 Dec 2020
At a glance
- Drugs Niclosamide (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2020 New trial record
- 08 Dec 2020 According to a Hyundai Bioscience media release, the company expect to initiate this trial in early January 2021 with the Korea Zoonosis Research Institute (KoZRI) of Jeonbuk National University which will be funded by the Korean government.